loadpatents
Patent applications and USPTO patent grants for Haque; Wasimul.The latest application filed is for "combination therapies to treat cardio- and cerebro-vascular disorders".
Patent | Date |
---|---|
Dual antiplatelet/anticoagulant pyridoxine analogs Grant 7,812,037 - Haque , et al. October 12, 2 | 2010-10-12 |
Combination Therapies to Treat Cardio- and Cerebro-Vascular Disorders App 20100069326 - Haque; Wasimul ;   et al. | 2010-03-18 |
Treatment of Diabetes and Related Pathologies App 20090018052 - Sethi; Rajat ;   et al. | 2009-01-15 |
Substituted Pyridoxines As Anti-Platelet Agents App 20080306108 - Haque; Wasimul ;   et al. | 2008-12-11 |
Aryl sulfonic pyridoxines as antiplatelet agents Grant 7,459,468 - Haque , et al. December 2, 2 | 2008-12-02 |
Cardioprotective phosphonates and malonates Grant 7,442,689 - Haque October 28, 2 | 2008-10-28 |
Pyridoxine and pyridoxal analogues: new uses Grant 7,425,570 - Haque September 16, 2 | 2008-09-16 |
Aryl Sulfonic Pyridoxines as Antiplatelet Agents App 20070142270 - Haque; Wasimul ;   et al. | 2007-06-21 |
Pyridoxal analogues and methods of treatment Grant 7,230,009 - Haque , et al. June 12, 2 | 2007-06-12 |
Treatment of cardiovascular and related pathologies Grant 7,148,233 - Sethi , et al. December 12, 2 | 2006-12-12 |
Treatment of cardiovascular and related pathologies Grant 7,144,892 - Sethi , et al. December 5, 2 | 2006-12-05 |
Treatment of cardiovascular and related pathologies Grant 7,132,430 - Sethi , et al. November 7, 2 | 2006-11-07 |
Novel heteroaryl phosphonates as cardioprotective agents App 20060241083 - Diakur; James ;   et al. | 2006-10-26 |
Treating of cardiovascular and related pathologies Grant 7,125,889 - Sethi , et al. October 24, 2 | 2006-10-24 |
Treatment of cardiovascular and related pathologies Grant 7,115,626 - Sethi , et al. October 3, 2 | 2006-10-03 |
Treatment of cardiovascular and related pathologies Grant 7,115,625 - Sethi , et al. October 3, 2 | 2006-10-03 |
Cardioprotective phosphonates and malonates Grant 7,105,673 - Haque September 12, 2 | 2006-09-12 |
Dual antiplatelet/anticoagulant pyridoxine analogs App 20060094761 - Haque; Wasimul ;   et al. | 2006-05-04 |
Substituted pyridoxines as anti-platelet agents App 20060094749 - Haque; Wasimul ;   et al. | 2006-05-04 |
Aryl sulfonic pyridoxines as antiplatelet agents App 20060094748 - Haque; Wasimul ;   et al. | 2006-05-04 |
Pyridoxine and pyridoxal analogues: new uses Grant 6,897,228 - Haque May 24, 2 | 2005-05-24 |
Pyridoxine and pyridoxal analogues: new uses App 20050107443 - Haque, Wasimul | 2005-05-19 |
Pyridoxal analogues and methods of treatment Grant 6,890,943 - Haque May 10, 2 | 2005-05-10 |
Cardioprotective phosphonates and malonates Grant 6,867,215 - Haque March 15, 2 | 2005-03-15 |
Treatment of cerebrovascular disease Grant 6,861,439 - Haque , et al. March 1, 2 | 2005-03-01 |
Treatment of diabetes and related pathologies App 20040235907 - Sethi, Rajat ;   et al. | 2004-11-25 |
Novel heteroaryl phosphonates as cardioprotective agents App 20040186077 - Diakur, James ;   et al. | 2004-09-23 |
Cardioprotective phosphonates and malonates App 20040171588 - Haque, Wasimul | 2004-09-02 |
Cardioprotective phosphonates and malonates Grant 6,780,997 - Haque August 24, 2 | 2004-08-24 |
Treatment of cerebrovascular disease App 20040121988 - Haque, Wasimul ;   et al. | 2004-06-24 |
Treatment of cardiovascular and related pathologies App 20040038945 - Sethi, Rajat ;   et al. | 2004-02-26 |
Treatment of cardiovascular and related pathologies App 20040033992 - Sethi, Rajat ;   et al. | 2004-02-19 |
Treatment of cardiovascular and related pathologies App 20040033990 - Sethi, Rajat ;   et al. | 2004-02-19 |
Treatment of cardiovascular and related pathologies App 20040033993 - Sethi, Rajat ;   et al. | 2004-02-19 |
Treating of cardiovascular and related pathologies App 20040033991 - Sethi, Rajat ;   et al. | 2004-02-19 |
Treatment of cardiovascular and related pathologies App 20040033989 - Sethi, Rajat ;   et al. | 2004-02-19 |
Pyridoxine and pyridoxal analogues: new uses App 20040010015 - Haque, Wasimul | 2004-01-15 |
Treatment of cardiovascular and related pathologies Grant 6,677,356 - Sethi , et al. January 13, 2 | 2004-01-13 |
Cardioprotective phosphonates and malonates Grant 6,667,315 - Haque December 23, 2 | 2003-12-23 |
Pyridoxal analogues and methods of treatment App 20030195236 - Haque, Wasimul | 2003-10-16 |
Cardioprotective phosphonates and malonates App 20030181422 - Haque, Wasimul | 2003-09-25 |
Cardioprotective phosohonates and malonates Grant 6,605,612 - Haque August 12, 2 | 2003-08-12 |
Treatment of cerebrovascular disease Grant 6,586,414 - Haque , et al. | 2003-07-01 |
Cardioprotective phosphonates and malonates App 20030120074 - Haque, Wasimul | 2003-06-26 |
Cardioprotective phosphonates and malonates App 20030114677 - Haque, Wasimul | 2003-06-19 |
Treatment of cerebrovascular disease App 20030114424 - Haque, Wasimul ;   et al. | 2003-06-19 |
Cardioprotective phosphonates and malonates App 20030114678 - Haque, Wasimul | 2003-06-19 |
Pyridoxine and pyridoxal analogues: novel uses Grant 6,548,519 - Haque April 15, 2 | 2003-04-15 |
Treatment of diabetes and related pathologies App 20030008847 - Sethi, Rajat ;   et al. | 2003-01-09 |
Cardioprotective phosphonates and malonates App 20020010158 - Haque, Wasimul | 2002-01-24 |
Treatment of cerebrovascular disease App 20010056081 - Haque, Wasimul ;   et al. | 2001-12-27 |
Pyridoxal analogues and methods of treatment App 20010031770 - Haque, Wasimul | 2001-10-18 |
Time dependent administration of oligosaccharide glycosides related to blood group determinants having a type I or type II core structure in reducing inflammation in a sensitized mammal arising form exposure to an antigen Grant 5,646,123 - Ippolito , et al. July 8, 1 | 1997-07-08 |
Immunosuppressive and tolerogenic modified Lewis.sup.x compounds Grant 5,580,858 - Ippolito , et al. December 3, 1 | 1996-12-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.